Publications by authors named "Neil Robertson"

Claim this Profile
E
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Jeremy Chataway, Thomas Williams, James Blackstone, Nevin John, Marie Braisher, Neil P Robertson

Lancet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis.
Lauren Griffiths, Kristen Hawkins, Eylan Yutuc, Roberto Angelini, Racheal Fosuah, Neil Robertson

Brain Pathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells.
Farah Jaber-Hijazi, Rouven Arnold, Karthic Swaminathan, Kathryn Gilroy, Alexander T Wenzel, Neil Robertson

Aging Cell· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis.
Laura Davies, Rasheed Shehadeh, W John Watkins, Stephen Jolles, Neil P Robertson

J Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical progression of clonal hematopoiesis is determined by a combination of mutation timing, fitness, and clonal structure.
Eric Latorre-Crespo, Neil A Robertson, E Gozde Kosebent, Louise MacGillivray, Lee Murphy

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton's tyrosine kinase inhibitor for multiple sclerosis: new hope or false dawn.
Neil P Robertson

J Neurol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the landscape and charting paths: UK neurology trainees' opinions on neuroinflammation subspecialty.
Tarunya Arun, Kate Petheram, Emma Tallantyre, Helen Ford, Jeremy Chataway, Neil Robertson

Mult Scler Relat Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in Wales.
Richard Nicholas, Emma Clare Tallantyre, James Witts, Ruth Ann Marrie, Elaine M Craig, Neil Robertson

J Neurol Neurosurg Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.
James Blackstone, Thomas Williams, Jennifer M Nicholas, Ekaterina Bordea, Floriana De Angelis, Neil Robertson

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of optical coherence tomography in neurodegenerative disease.
Jonathan Hawken, Neil Robertson

J Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.
Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Neil P Robertson

Mult Scler· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world persistence of multiple sclerosis disease-modifying therapies.
Emma C Tallantyre, Ruth Dobson, Joseph L J Froud, Frederika A St John, Valerie M Anderson, Neil P Robertson

Eur J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermally activated delayed fluorescence emitters for efficient sensitization of europium(III).
Neena K Kalluvettukuzhy, Michal R Maciejczyk, Neil Robertson

Phys Chem Chem Phys· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the treatment of the muscular dystrophies.
Callum Wood, Neil P Robertson

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort.
Emeka C Uzochukwu, Katharine E Harding, James Hrastelj, Karim L Kreft, Peter Holmans, Neil P Robertson

Neuroepidemiology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic criteria for MOGAD.
Sophie Voase, Neil P Robertson

J Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Moneeb Nasir, Luke Hone, Emma Tallantyre, Patricia Kelly, Maria Isabel Leite, Neil Robertson

Mult Scler Relat Disord· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodromal multiple sclerosis: considerations and future utility.
Katharine E Harding, Karim L Kreft, Yoav Ben-Shlomo, Neil P Robertson

J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials.
Yasmin Zid, Neil P Robertson

J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Karim L Kreft, Emeka Uzochukwu, Sam Loveless, Mark Willis, Ray Wynford-Thomas, Neil P Robertson

Ann Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional control of leukemogenesis by the chromatin reader SGF29.
Karina Barbosa, Anagha Deshpande, Marlenne Perales, Ping Xiang, Rabi Murad, Neil Robertson

Blood· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel biomarkers and neuroimaging techniques in Parkinson's disease.
A Saw, S Bari, Neil P Robertson

J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Eleftheria Kodosaki, W John Watkins, Sam Loveless, Karim L Kreft, Aidan Richards, Neil P Robertson

J Neuroinflammation· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cavernomas: to treat or not to treat?
Sophie Voase, Neil P Robertson

J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-ray crystallographic analysis of the antiferromagnetic low-temperature phase of galvinoxyl: investigating magnetic duality in organic radicals.
Rie Suizu, Yoshiaki Shuku, Vincent Robert, Pablo Roseiro, Nadia Ben Amor, Neil Robertson

Dalton Trans· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis